Literature DB >> 29380298

Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women's breast cancer tumors.

Nassim Faridi1, S Zahra Bathaie2, Saeid Abroun3, Parvaneh Farzaneh4, Hamid Karbasian5, Fuyuhiko Tamanoi6, Mohammad-Ali Mohagheghi7.   

Abstract

As an experimental model, most studies rely on established human cancer cell lines; however, some genetical or phenotypical differences exist between these cells and their original tumor. Therefore, primary cells isolated directly from tissue are believed to be more biologically relevant tools for studying human and animal biology. Here, we aimed to isolate primary epithelial cancer and normal cells from breast tumors of Iranian women, for the first time. Thus, we isolated the epithelial and fibroblast cells from biopsy samples of patients with breast cancer based on differential centrifugation followed by culture in selective media. Normal epithelial cells obtained from the tissue biopsy away from the core of the tumor, based on the pathological diagnosis. Flow cytometry analysis indicated the positive immunoreactivity of the isolated epithelial cells against CD24 and Epithelial Specific Antigen (ESA/EpCAM), while they displayed a concomitant low expression of CD44 and CD49f. In contrat to fibroblasts, the qPCR data indicated the expression of luminal intracellular cytokeratin (Ck18) in both normal and cancer epithelial cells, but there was no expression of myoepithelial/basal markers, CK5 and vimentin. The epithelial cancer cells were reactive to cytokeratin 19 (CK19) antibody, whereas the normal epithelial cells were not. The expression of calmodulin-like protein (CLP) was also lower in the cancer epithelial cells than in the normal ones. In conclusion, primary epithelial normal and cancer cells, in addition to the fibroblasts were isolated and characterized from breast tumor of Iranian patients; and CLP expression is suggested as a susceptibility marker for breast cancer screening.

Entities:  

Keywords:  CD24; CD44; CLP; Cytokeratin; EpCAM; Primary breast cell

Year:  2018        PMID: 29380298      PMCID: PMC5851957          DOI: 10.1007/s10616-017-0159-3

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  73 in total

1.  CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Authors:  Sema Bircan; Nilgun Kapucuoglu; Sirin Baspinar; Gulsun Inan; Ozden Candir
Journal:  Pathol Res Pract       Date:  2006-07-07       Impact factor: 3.250

2.  Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report.

Authors:  Seyed Behzad Jazayeri; Soheil Saadat; Rashid Ramezani; Ahmad Kaviani
Journal:  Cancer Epidemiol       Date:  2015-06-10       Impact factor: 2.984

3.  CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells.

Authors:  S Aigner; Z M Sthoeger; M Fogel; E Weber; J Zarn; M Ruppert; Y Zeller; D Vestweber; R Stahel; M Sammar; P Altevogt
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

4.  Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.

Authors:  Puay-Hoon Tan; Boon-Huat Bay; George Yip; Sathiyamoorthy Selvarajan; Patrick Tan; Jeanie Wu; Chee-How Lee; Kuo-Bin Li
Journal:  Mod Pathol       Date:  2005-03       Impact factor: 7.842

5.  The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.

Authors:  Leigh Samsel; Grazyna Zaidel; Honesty M Drumgoole; Danijela Jelovac; Cinthia Drachenberg; Juong G Rhee; Angela M H Brodie; Alicja Bielawska; Miriam J Smyth
Journal:  Prostate       Date:  2004-03-01       Impact factor: 4.104

6.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.

Authors:  S L Hammond; R G Ham; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes.

Authors:  Felicia Leccia; Agostina Nardone; Sara Corvigno; Luigi Del Vecchio; Sabino De Placido; Francesco Salvatore; Bianca Maria Veneziani
Journal:  Cytometry A       Date:  2012-07-12       Impact factor: 4.355

9.  Short-term primary culture of epithelial cells derived from human breast tumours.

Authors:  V Speirs; A R Green; D S Walton; M J Kerin; J N Fox; P J Carleton; S B Desai; S L Atkin
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

10.  Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation.

Authors:  Michael D Brooks; Richard D Bennett; Amy L Weaver; Thomas J Sebo; Steven E Eckert; Emanuel E Strehler; Alan B Carr
Journal:  Int J Dent       Date:  2013-07-08
View more
  3 in total

1.  Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway.

Authors:  Eunji Kang; Kanggeon Kim; Sook Young Jeon; Ji Gwang Jung; Hong-Kyu Kim; Han-Byoel Lee; Wonshik Han
Journal:  Cancer Gene Ther       Date:  2022-01-19       Impact factor: 5.854

2.  Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.

Authors:  Anne Menz; Timo Weitbrecht; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Ronald Simon
Journal:  Mol Med       Date:  2021-02-15       Impact factor: 6.354

3.  Silver nanoparticles achieve cytotoxicity against breast cancer by regulating long-chain noncoding RNA XLOC_006390-mediated pathway.

Authors:  Lin Tao; Xi Chen; Jiawei Sun; Changjun Wu
Journal:  Toxicol Res (Camb)       Date:  2021-01-22       Impact factor: 3.524

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.